Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$296.48 - $337.87 $1.52 Million - $1.73 Million
5,134 New
5,134 $1.66 Million
Q1 2021

May 19, 2021

SELL
$164.32 - $212.72 $67,206 - $87,002
-409 Closed
0 $0
Q4 2020

Mar 09, 2021

BUY
$130.46 - $172.63 $53,358 - $70,605
409 New
409 $69,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tru Independence Asset Management 2, LLC Portfolio

Follow Tru Independence Asset Management 2, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.